 We think that Boston Scientific stock currently is a better pick compared to its industry peer, Medtronic stock, despite it being the more expensive of the two, trading at 5.3x trailing revenues compared to 4.4x for Medtronic. Even if we were to look at the PEBIT ratio, BSX stock appears to be. 